GATEWAY FOR CANCER RESEARCH INVITES YOU TO FOLLOW THE YELLOW BRICK ROAD
AS “GATEWAY TO OZ” TAKES CENTER STAGE ON SATURDAY, NOVEMBER 18, 2017
IN THE GRAND BALLROOM AT MCCORMICK PLACE:
“EARTH, WIND & FIRE” LEADS THE WORLD-RENOWNED ENTERTAINMENT ROSTER
AT CHICAGO’S ANNUAL STAR-STUDDED GALA
CHICAGO (October 18, 2017) -- Gateway for Cancer Research (Gateway) founder Richard J Stephenson and Dr. Stacie J. Stephenson announce world-renowned entertainment for the annual Cures Gala, “Gateway to OZ,” beginning at 5:00 p.m. on November 18, 2017 in the Grand Ballroom at McCormick Place, 2301 South King Drive, Chicago. The Emerald City-worthy event will rock with the legendary R&B band that changed the sounds of pop for all times, Earth, Wind & Fire.
Click your heels along a magical journey, beginning with a unique culinary experience and followed by a first-class entertainment roster including Matteo Bocelli, son of Andrea Bocelli performing for the first time in Chicago; Billy Gilman, the youngest singer to ever reach #1 on the Billboard Top Country Album charts; Laura Breton, America’s Got Talent finalist and “Golden Buzzer” winner; and Letitia Frye, America’s foremost “auctiontainer.”
Celebrating 26 years of Gateway-funded groundbreaking clinical research trials, Gateway to OZ is co-chaired and presented by Richard J Stephenson, founder and chairman of Cancer Treatment Centers of America® (CTCA) and Gateway for Cancer Research and Dr. Stacie J. Stephenson, CTCA Chairman Functional Medicine and Gateway Board of Directors; and honorary chair Jim Gordon, Founder & Managing Partner of The Edgewater Funds.
Tickets are $1,000 per person. For sponsorship opportunities, contact firstname.lastname@example.org or call 866-932-4208.
All proceeds from “Gateway to OZ” will help support Gateway for Cancer Research Phase I and Phase II trials across cancer types, including breast, blood and lung cancers.
ABOUT GATEWAY FOR CANCER RESEARCH
“Our mission instills a sense of urgency to accelerate the pace of cancer research,” said Teresa Hall Bartels, president, Gateway for Cancer Research. “Our dedication to investing in novel patient-centric approaches, combined with the increasing rate of treatment advances, leads us to believe that together we can conquer cancer in our lifetime.”
Gateway for Cancer Research℠ is a nonprofit 501(c)(3) organization committed to funding innovative cancer research that helps people living with cancer to feel better, live longer and conquer cancer TODAY! Thanks to generous underwriting, 99 cents of every dollar Gateway receives directly funds Phase I and Phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991, Gateway has supported more than 150 clinical trials and funded over $70 million in breakthrough cancer research. Get involved today by visiting www.GatewayCR.org, like us on Facebook at facebook.com/demandcures and join the conversation on Twitter at @DemandCures, #BeAGateway.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial